KOBAYASHI PHARMACEUTICAL CO.,LTD.JP:4967Income statement

Market cap
¥449.3B
P/E ratio
42.8x
2012/032013/032014/032015/032016/032016/122017/122018/122019/122020/122021/122022/122023/122024/122025/12
Revenue131,166121,532127,293128,344137,211120,051156,761167,479168,052150,514155,252166,258173,455165,600165,742
Revenue growth (%)-
Cost of revenue---54,71857,51848,63861,23864,35964,70565,24866,47873,92777,07977,99781,030
Gross profit---73,62679,69371,41295,522103,119103,34685,26588,77392,33196,37587,60384,711
Gross margin (%)---
Operating margin (%)---
Operating expenses ---55,70861,43254,00372,59676,83076,99159,32262,70765,66270,59562,74269,788
Operating income ---17,91718,26017,40922,92526,28926,35525,94326,06526,66925,78024,86014,923
Income before tax 20,09218,67718,76918,84317,94919,49924,19127,37427,85127,72628,01528,28127,33026,86116,995
Pretax margin (%)15.315.414.714.713.116.215.416.316.618.4181715.816.210.3
Provision for income taxes---7,6085,3005,5446,7097,2807,6657,4307,9207,9277,2213,84283
Effective tax rate (%)---
Net income 9,98112,84910,80412,44813,46614,32115,86318,02319,13919,20519,71520,02220,33810,0713,660
Earnings per share286.36297.37300.55305.46331.11179.12201.31228.05244.08245.71252.36259.63268.16135.4249.19
Diluted EPS----330.6178.86201.03227.95---259.59---
Dividend payout ratio (%)--------------
Dividend per share--------73778390101102104